| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.089 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.098 | 0.8 |